← Back to headlines
US Executive Action to Advance Ibogaine Research Welcomed by Psyence BioMed
Psyence BioMed has welcomed a recent U.S. executive action aimed at advancing research into Ibogaine, a psychedelic compound with potential therapeutic applications.
17 Apr, 13:15 — 17 Apr, 13:15
Sources
Showing 1 of 1 sources
Related Stories
UNICEF Report Finds 20 Million Children Annually Face Online Sexual Exploitation
1h ago
Genetically Modified Pig Kidney Keeps US Patient Alive for Record Nine Months
1h ago
Pentagon Temporarily Rescinds Testosterone Screening Guidance for Troops
3h ago
RFK Jr. Allegedly Requested Removal of Measles Deaths From CDC Tally
5h ago